SAM CHUN DANG PHARM Co., Ltd.

ISIN KR7000250001

 | 

WKN A0RKZC

Market cap (in EUR)
14,993 m
Country
South Korea
Sector
Healthcare
Dividend yield
0.01%
 

Overview

Description

SAM CHUN DANG PHARM Co., Ltd. engages in the manufacture and sale of pharmaceuticals. Its products include antibiotics, cures for the circulatory and respiratory system, medicines for the digestive system and ophthalmology, and anti-inflammatory. The company was founded on December 29, 1943 and is headquartered in Hwaseong-si, South Korea.
Show more Show less
Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals South Korea

Financials

Key metrics

Market capitalisation, EUR 14,993 m
EPS, EUR 0.14
P/B ratio 93.6
P/E ratio 4,910.7
Dividend yield 0.01%

Income statement (2025)

Revenue, EUR 145 m
Net income, EUR 3 m
Profit margin 2.27%

What ETF is SAM CHUN DANG PHARM Co., Ltd. in?

There are 4 ETFs which contain SAM CHUN DANG PHARM Co., Ltd.. All of these ETFs are listed in the table below. The ETF with the largest weighting of SAM CHUN DANG PHARM Co., Ltd. is the iShares MSCI Emerging Markets Small Cap UCITS ETF.
ETF Weight Investment focus Fund size (in m EUR)
iShares MSCI Emerging Markets Small Cap UCITS ETF 0.46%
Equity
Emerging Markets
Small Cap
286
Vanguard ESG Developed Asia Pacific All Cap UCITS ETF (USD) Distributing 0.09%
Equity
Asia Pacific
Social/Environmental
35
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.01%
Equity
World
Social/Environmental
452
iShares MSCI EM IMI Screened UCITS ETF USD (Dist) 0.06%
Equity
Emerging Markets
Social/Environmental
1,145
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.